ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members.
The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process.
In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.

See more Open Access Option

Indexed in:

Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.208

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.273

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original Article

Response, complications and risk of leukemic transformation of phosphorus-32p treatment in philadelphia-negative chronic myeloproliferative syndromes

Respuesta, complicaciones y riesgo de transformación leucémica del tratamiento con fósforo-32p en los síndromes mieloproliferativos crónicos philadelphia negativos.

I. Tobalina Larreaa,b,

Corresponding author

ignacio.tobalinalarrea@osakidetza.eus

Corresponding author.

, J. Cuetos Fernándezc, A. Mendizabal Abadd, A. Montero de la Peñaa, D. García Hernándeza, G.H. Portilla Quatrociocchie, M. Jiménez Alonsoe, M.C. Menchaca Echevarriad

a Servicio de Medicina Nuclear, Hospital Universitario de Álava, Osakidetza, Vitoria-Gasteiz, Álava, Spain

b Facultad de Medicina, Departamento de Cirugía, Radiología y Medicina Física, Universidad del País Vasco, UPV/EHU, Unidad Docente de Vitoria-Gasteiz, Vitoria-Gasteiz, Álava, Spain

c Servicio de Radiología, Hospital Universitario Donostia, Osakidetza, Donostia-San Sebastián, Guipúzcoa, Spain

d Servicio de Hematología y Hemoterapia, Hospital Universitario de Álava, Osakidetza, Vitoria-Gasteiz, Álava, Spain

e Servicio de Medicina Nuclear, Hospital Universitario de Cruces, Osakidetza, Baracaldo-Cruces, Vizcaya, Spain

Read

Not available

Times
was read the article

Total PDF

Total HTML

Share statistics

Article information

ISSN: 22538089
Original language: English

DOI:10.1016/j.remnie.2024.500064

The statistics are updated each day

Follow this link to access the full text of the article

Publish in

Revista Española de Medicina Nuclear e Imagen Molecular

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Free access articles

Imaging of desmoplastic small round-cell tumor on

Rev Esp Med Nucl Imagen Mol. 2024;43:

Assessment of incidental cardiac uptake in bone...

Rev Esp Med Nucl Imagen Mol. 2024;43:

Diagnostic performance of a novel deep learning attenuation...

Rev Esp Med Nucl Imagen Mol. 2024;43:23-30

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter